Premitotic chromosome individualization in mammalian cells depends on topoisomerase II activity

被引:49
|
作者
Giménez-Abián, JF
Clarke, DJ
Devlin, J
Giménez-Abián, MI
De la Torre, C
Johnson, RT
Mullinger, AM
Downes, CS
机构
[1] CSIC, Ctr Invest Biol, E-28006 Madrid, Spain
[2] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA
[3] Univ Ulster, Coleraine BT52 1SA, Londonderry, North Ireland
[4] Coriell Inst Med Res, Camden, NJ 08103 USA
[5] Univ Cambridge, Dept Zool, Cambridge, England
关键词
D O I
10.1007/s004120000065
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
When DNA topoisomerase II (topo II) activity is inhibited with a non-DNA-damaging topo TI inhibitor (ICRF-193), mammalian cells become checkpoint arrested in G2-phase. In this study, we analyzed chromosome structure ill cells that bypassed this checkpoint. We observed a novel type of chromosome aberration, which we call R-figures. These are entangled chromosome regions that indicate the persistence of catenations between nonhomologous sequences. The number of Omega-figures per cell increased sharply as cells evaded the transient block imposed by the topo II-dependent checkpoint, and the presence of caffeine (a checkpoint-evading agent) potentiated this increase. Thus, the removal of nonreplicative catenations, a process that promotes chromosome individualization in G2, may be monitored by the topo II-dependent checkpoint in mammals.
引用
收藏
页码:235 / 244
页数:10
相关论文
共 50 条
  • [21] Coralyne and related compounds as mammalian topoisomerase I and topoisomerase II poisons
    Makhey, D
    Gatto, B
    Yu, CA
    Liu, A
    Liu, LF
    LaVoie, EJ
    BIOORGANIC & MEDICINAL CHEMISTRY, 1996, 4 (06) : 781 - 791
  • [22] Topoisomerase II inhibitors affect entry into mitosis and chromosome condensation in BHK cells
    Anderson, H
    Roberge, M
    CELL GROWTH & DIFFERENTIATION, 1996, 7 (01): : 83 - 90
  • [23] Defective Brca2 influences topoisomerase I activity in mammalian cells
    Rahden-Staron, I
    Szumilo, M
    Grosicka, E
    Kraakman-van der Zwet, M
    Zdzienicka, MZ
    ACTA BIOCHIMICA POLONICA, 2003, 50 (01) : 139 - 144
  • [24] Influence of elsamicin A on the activity of mammalian topoisomerase I
    RodriguezCampos, A
    Azorin, F
    Portugal, J
    BIOCHEMISTRY, 1996, 35 (34) : 11177 - 11182
  • [25] ALTERED DNA TOPOISOMERASE-II ACTIVITY IN CHINESE-HAMSTER CELLS RESISTANT TO TOPOISOMERASE-II INHIBITORS
    POMMIER, Y
    KERRIGAN, D
    SCHWARTZ, RE
    SWACK, JA
    MCCURDY, A
    CANCER RESEARCH, 1986, 46 (06) : 3075 - 3081
  • [26] Nitric oxide inhibits topoisomerase II activity and induces resistance to topoisomerase II-poisons in human tumor cells
    Kumar, Ashutosh
    Ehrenshaft, Marilyn
    Tokar, Erik J.
    Mason, Ronald P.
    Sinha, Birandra K.
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 2016, 1860 (07): : 1519 - 1527
  • [27] NETROPSIN AND BIS-NETROPSIN ANALOGS AS INHIBITORS OF THE CATALYTIC ACTIVITY OF MAMMALIAN DNA TOPOISOMERASE-II AND TOPOISOMERASE CLEAVABLE COMPLEXES
    BEERMAN, TA
    WOYNAROWSKI, JM
    SIGMUND, RD
    GAWRON, LS
    RAO, KE
    LOWN, JW
    BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1090 (01) : 52 - 60
  • [28] Effects of resveratrol on topoisomerase II-α activity: induction of micronuclei and inhibition of chromosome segregation in CHO-K1 cells
    Basso, Emiliano
    Fiore, Mario
    Leone, Stefano
    Degrassi, Francesca
    Cozzi, Renata
    MUTAGENESIS, 2013, 28 (03) : 243 - 248
  • [29] CLEAVAGE OF DNA BY MAMMALIAN DNA TOPOISOMERASE-II
    LIU, LF
    ROWE, TC
    YANG, L
    TEWEY, KM
    CHEN, GL
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1983, 258 (24) : 5365 - 5370
  • [30] MAMMALIAN-CELLS CONTAIN A DNA-RECOMBINING ACTIVITY THAT CAN BE DISSOCIATED FROM TOPOISOMERASE ACTIVITY
    HAMELIN, C
    ALAIN, R
    HOUDE, D
    BERTHIAUME, L
    BIOSCIENCE REPORTS, 1982, 2 (07) : 527 - 533